Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in Mixed Depression
IRCT201202122935N7Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aripiprazole in major depressive disorder (MDD), sponsored by Kurdistan University of Medical Sciences. Started Dec 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT201202122935N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201202122935N7.